GSK PE Ratio 2010-2022 | GSK

Current and historical p/e ratio for GSK (GSK) from 2010 to 2022. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. GSK PE ratio as of December 02, 2022 is 9.01.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

GSK PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2022-12-02 35.35 4.33
2022-09-30 29.15 $8.16 3.57
2022-06-30 53.31 $3.02 17.65
2022-03-31 52.93 $3.46 15.29
2021-12-31 52.82 $3.00 17.61
2021-09-30 45.20 $2.95 15.32
2021-06-30 46.53 $2.96 15.71
2021-03-31 41.15 $3.41 12.06
2020-12-31 41.66 $3.68 11.34
2020-09-30 42.04 $4.06 10.35
2020-06-30 45.02 $4.21 10.69
2020-03-31 41.34 $3.43 12.07
2019-12-31 50.60 $2.98 17.01
2019-09-30 45.44 $2.93 15.53
2019-06-30 42.13 $2.90 14.53
2019-03-31 43.47 $2.59 16.80
2018-12-31 39.16 $2.43 16.15
2018-09-30 40.69 $1.26 32.23
2018-06-30 40.34 $1.14 35.47
2018-03-31 38.62 $0.71 54.20
2017-12-31 34.44 $0.99 34.88
2017-09-30 38.87 $1.53 25.49
2017-06-30 40.76 $1.25 32.61
2017-03-31 39.40 $1.04 37.97
2016-12-31 35.49 $0.59 60.41
2016-09-30 39.29 $0.15 261.94
2016-06-30 39.07 $0.04 1041.85
2016-03-31 36.13 $0.48 76.06
2015-12-31 34.86 $6.56 5.31
2015-09-30 32.78 $7.64 4.29
2015-06-30 35.05 $7.55 4.64
2015-03-31 38.33 $8.01 4.78
2014-12-31 34.99 $2.29 15.29
2014-09-30 37.13 $3.54 10.50
2014-06-30 42.61 $4.00 10.65
2014-03-31 42.09 $4.24 9.93
2013-12-31 41.50 $4.43 9.38
2013-09-30 38.54 $3.09 12.48
2013-06-30 37.98 $3.20 11.87
2013-03-31 35.27 $3.38 10.45
2012-12-31 32.19 $3.68 8.76
2012-09-30 33.78 $3.94 8.58
2012-06-30 32.92 $4.10 8.03
2012-03-31 32.06 $3.99 8.04
2011-12-31 31.98 $4.11 7.78
2011-09-30 28.58 $2.60 10.99
2011-06-30 29.34 $2.50 11.74
2011-03-31 25.96 $1.40 18.54
2010-12-31 26.08 $1.21 21.51
2010-09-30 25.95 $3.05 8.51
2010-06-30 22.05 $3.15 7.00
2010-03-31 24.66 $4.54 5.43
2009-12-31 26.64 $4.34 6.14
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $71.890B $46.910B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $172.495B 10.52
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.433B 19.52
Ginkgo Bioworks Holdings (DNA) United States $3.861B 0.00
Myovant Sciences (MYOV) United Kingdom $2.605B 0.00
Arcus Biosciences (RCUS) United States $2.586B 38.81
Biohaven (BHVN) United States $1.141B 0.00
Emergent Biosolutions (EBS) United States $0.599B 4.71
Zymeworks (ZYME) Canada $0.478B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.278B 0.00
Enzo Biochem (ENZ) United States $0.096B 0.00
SQZ Biotechnologies (SQZ) United States $0.046B 0.00
Gelesis Holdings (GLS) United States $0.035B 0.00
Ambrx Biopharma (AMAM) United States $0.019B 0.00